Schedule 13D ownership disclosure

HISTOGENICS CORP

Security class unavailable · CUSIP: 43358V109

Event date: 2014-12-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,384,694
Percent of class
10.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-14-086430
Form type
SC 13D
Filer
Ocugen, Inc.
CIK
CIK 1372299
Filed
Dec 12, 2014
Reporting period
Dec 02, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub